Jie Cai

University of Southern California — United States

Medicine · Health Sciences

22h-index2.6kcitations61works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Drug Transport and Resistance Mechanisms(10), Bacterial Genetics and Biotechnology(5), Liver Disease Diagnosis and Treatment(5), Legume Nitrogen Fixing Symbiosis(5), Epigenetics and DNA Methylation(4)

Publications61 total

Treatment Options for Polycystic Ovary Syndrome
Obstetrics and gynecology.·2025Open Access
Decoding the roles of CCL11 in human malignancies and clinical implications
Biochemical Pharmacology·2025
Membrane Tension Gates AT2 Fate Selection by Regulating FGF Signaling
American Journal of Respiratory and Critical Care Medicine·2025
OUTCOMES FOLLOWING NEOADJUVANT CISPLATIN-BASED CHEMOTHERAPY AND CYSTECTOMY FOR MUSCLE INVASIVE UROTHELIAL CARCINOMA WITH CONCOMITANT CARCINOMA IN SITU
Urologic Oncology Seminars and Original Investigations·2025
Searching for a New Homeland: How Geography Matters in the College Selection and Career Decisions of STEM PhDs
Journal of STEM Education Innovations and Research·2024Open Access
Body composition, lifestyle, and depression: a prospective study in the UK biobank
BMC Public Health·2024· 18 citedOpen Access
Discovery of Natural Potent HMG‐CoA Reductase Degraders for Lowering Cholesterol
Angewandte Chemie·2023· 2 citedOpen Access
Discovery of Natural Potent HMG‐CoA Reductase Degraders for Lowering Cholesterol
Angewandte Chemie International Edition·2023· 25 cited
Bile salt hydrolase in non-enterotoxigenic Bacteroides potentiates colorectal cancer
Nature Communications·2023· 104 citedOpen Access
Gut bacteria alleviate smoking-related NASH by degrading gut nicotine
Nature·2022· 191 citedOpen Access
Development of DNA Vaccine Candidate against SARS-CoV-2
Viruses·2022· 10 citedOpen Access
<scp>CXCR4</scp> antagonist <scp>AMD3100</scp> enhances therapeutic efficacy of transcatheter arterial chemoembolization in rats with hepatocellular carcinoma
The Kaohsiung Journal of Medical Sciences·2022· 8 citedOpen Access
Intestinal peroxisome proliferator‐activated receptor α‐fatty acid‐binding protein 1 axis modulates nonalcoholic steatohepatitis
Hepatology·2022· 106 citedOpen Access
Gut microbiota-derived bile acids in intestinal immunity, inflammation, and tumorigenesis
Cell Host & Microbe·2022· 726 citedOpen Access
Identification of Tumor Antigens and Design of mRNA Vaccine for Colorectal Cancer Based on the Immune Subtype
Frontiers in Cell and Developmental Biology·2022· 21 citedOpen Access
Rosuvastatin alleviated the liver ischemia reperfusion injury by activating the expression of peroxisome proliferator-activated receptor gamma (PPARγ)
Journal of Bioenergetics and Biomembranes·2021· 9 cited
Intestinal MYC modulates obesity-related metabolic dysfunction
Nature Metabolism·2021· 49 citedOpen Access
Manassantin B attenuates obesity by inhibiting adipogenesis and lipogenesis in an AMPK dependent manner
The FASEB Journal·2021· 6 citedOpen Access
Myelocytomatosis‐Protein Arginine N‐Methyltransferase 5 Axis Defines the Tumorigenesis and Immune Response in Hepatocellular Carcinoma
Hepatology·2021· 56 citedOpen Access
The role of farnesoid X receptor in metabolic diseases, and gastrointestinal and liver cancer
Nature Reviews Gastroenterology & Hepatology·2021· 376 cited
page 1 of 4Next →

Frequent Co-authors

Lulu Sun(8), Frank J. Gonzalez(8), Yuhong Luo(6), Michael S. DuBow(6), Piet Gros(6), Kristopher W. Krausz(5), Zhi‐Ping Xie(4), Christian Staehelin(4), Elias Georges(4), Changtao Jiang(3), Shoumei Yang(3), Weiwei Liu(3), Shogo Takahashi(3), Ru‐Jie Li(3), Roni Daoud(3), Chanjuan Li(3), Jun Xu(3), Oksana Gavrilova(2), Xuan Wu(2), Aijuan Qu(2)